title: Complement-fixing properties of antinuclear antibodies distinguish drug-induced lupus from systemic lupus erythematosus.
abstract: The immunofluorescence antinuclear antibody (ANA) test has been widely used to monitor autoimmune disease, but its value for diagnostic purposes is compromised by low specificity and high prevalence in disease-free individuals. The capacity of autoantibodies to fix serum complement proteins when bound to antigen is an important effector function because this property is associated with acute and chronic inflammatory processes. The current study evaluates the complement-fixing properties of antinuclear antibodies (CANA) in three well-defined and clinically-related patient groups: systemic lupus erythematosus (SLE), drug-induced lupus (DIL) and drug-induced autoimmunity (DIA). Of 20 patients diagnosed with SLE, 90% displayed complement-fixing ANA while this feature was present in only two of 18 patients with DIL and no patients with DIA without associated disease even though the mean ANA titres were similar among these patient groups. CANA was significantly correlated with anti-Sm activity. Because SLE but not DIL or DIA can be a life-threatening disease associated with complement consumption in vivo, these results demonstrate that measurement of CANA is a diagnostically useful tool and may have immunopathologic implications.
authors.affiliation: Department of Molecular Genetics and Microbiology, University of New Mexico Medical School, Albuquerque, New Mexico 87131, USA. rlrubin@saiud.unm.edu
authors.forename: R L
authors.initials: RL
authors.lastname: Rubin
authors.forename: M
authors.initials: M
authors.lastname: Teodorescu
authors.forename: E H
authors.initials: EH
authors.lastname: Beutner
authors.forename: R W
authors.initials: RW
authors.lastname: Plunkett
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000974:Antibodies, Antinuclear / Q000276:immunology*; D001327:Autoimmune Diseases / Q000139:chemically induced / Q000175:diagnosis; D003168:Complement Fixation Tests; D003165:Complement System Proteins / Q000276:immunology*; D003937:Diagnosis, Differential; D005260:Female; D005455:Fluorescent Antibody Technique; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000175:diagnosis* / Q000276:immunology*; D008177:Lupus Vulgaris / Q000139:chemically induced* / Q000175:diagnosis / Q000276:immunology*; D008297:Male; D008856:Microscopy, Fluorescence; D008875:Middle Aged
chemical_list: D000974:Antibodies, Antinuclear; D003165:Complement System Proteins